FDA Adverse Event Injury Summary report: N

PROLIFT PELVIC FLOOR REPAIR

MDR report key: 2973302 · Received February 21, 2013

Report

Report Number
2210968-2013-01585
Event Type
Injury
Date Received
February 21, 2013
Report Date
January 29, 2013
Manufacturer
ETHICON INC
Product Code
OTP
PMA / PMN Number
K013718
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MO, US
Reporter Occupation
ATTORNEY

Narratives

Additional Manufacturer Narrative · 1

(B)(4): NO CONCLUSION CAN BE DRAWN AT THIS TIME. SHOULD ADDITIONAL INFORMATION BE OBTAINED, A SUPPLEMENTAL 3500A FORM WILL BE SUBMITTED ACCORDINGLY.

Additional Manufacturer Narrative · 1

(B)(4). ADDITIONAL NARRATIVE: IT WAS REPORTED THAT MESH WAS IMPLANTED ALONG WITH CONCURRENT SUTURE OF ACCIDENTAL LACERATION TO BLADDER, CYSTOCELE REPAIR DUE TO ANTERIOR VAGINAL PROLAPSED. FOLLOWING IMPLANTATION THE PATIENT EXPERIENCED PAIN, EROSION, EXTRUSION, INFECTION, URINARY PROBLEMS, RECURRENCE, DYSPAREUNIA, NEUROMUSCULAR PROBLEMS AND VAGINAL SCARRING. IT WAS REPORTED THAT PATIENT UNDERWENT CYSTOSCOPY AND EXCISION ON (B)(6) 2012 OF VAGINAL GRAFT DUE TO VAGINAL GRAFT EROSION. (B)(4) ¿ URINARY PROBLEMS; UNDEFINED RECURRENCE; NEUROMUSCULAR PROBLEMS.

Additional Manufacturer Narrative · 1

IT WAS REPORTED THAT THE PATIENT UNDERWENT MESH REMOVAL ON (B)(6) 2015 BY (B)(6).

Description of Event or Problem · 1

IT WAS REPORTED THAT THE PATIENT UNDERWENT A GYNECOLOGICAL PROCEDURE ON (B)(6) 2006 AND A MESH WAS IMPLANTED. THE PATIENT EXPERIENCED PAIN, EROSION OF HER INTERNAL BODILY TISSUE AND OTHER INJURIES FOLLOWING THE PROCEDURE. THE PATIENT HAS UNDERGONE MULTIPLE SURGERIES AND REVISIONARY PROCEDURES. NO ADDITIONAL INFORMATION WAS PROVIDED.

Description of Event or Problem · 1

IT WAS REPORTED THAT THE PATIENT UNDERWENT MESH REMOVAL ON (B)(6) 2015 BY (B)(6).

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
75804 PROLIFT PELVIC FLOOR REPAIR MESH, SURGICAL, POLYMERIC OTP ETHICON INC NA 1362894

Patients

Seq Age Sex Outcome Treatment
1 55 YR Required Intervention